<VariationArchive VariationID="428112" VariationName="NM_000038.6(APC):c.4666dup (p.Thr1556fs)" VariationType="Duplication" Accession="VCV000428112" Version="23" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2017-06-25" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="419660" VariationID="428112">
      <GeneList>
        <Gene Symbol="APC" FullName="APC regulator of WNT signaling pathway" GeneID="324" HGNC_ID="HGNC:583" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="112707498" stop="112846239" display_start="112707498" display_stop="112846239" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="112043201" stop="112181935" display_start="112043201" display_stop="112181935" Strand="+" />
          </Location>
          <OMIM>611731</OMIM>
          <Haploinsufficiency last_evaluated="2021-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000038.6(APC):c.4666dup (p.Thr1556fs)</Name>
      <CanonicalSPDI>NC_000005.10:112840254:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="112840254" stop="112840255" display_start="112840254" display_stop="112840255" variantLength="1" positionVCF="112840254" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="112175951" stop="112175952" display_start="112175951" display_stop="112175952" variantLength="1" positionVCF="112175951" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>T1273fs</ProteinChange>
      <ProteinChange>T1465fs</ProteinChange>
      <ProteinChange>T1515fs</ProteinChange>
      <ProteinChange>T1538fs</ProteinChange>
      <ProteinChange>T1574fs</ProteinChange>
      <ProteinChange>T1396fs</ProteinChange>
      <ProteinChange>T1455fs</ProteinChange>
      <ProteinChange>T1497fs</ProteinChange>
      <ProteinChange>T1556fs</ProteinChange>
      <ProteinChange>T1430fs</ProteinChange>
      <ProteinChange>T1528fs</ProteinChange>
      <ProteinChange>T1531fs</ProteinChange>
      <ProteinChange>T1566fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_130" sequenceAccession="LRG_130" change="g.152740dup">
            <Expression>LRG_130:g.152740dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.112840260dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.112840260dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.112175957dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.112175957dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008481.4" sequenceAccession="NG_008481" sequenceVersion="4" change="g.152740dup">
            <Expression>NG_008481.4:g.152740dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000038.6" sequenceAccession="NM_000038" sequenceVersion="6" change="c.4666dup" MANESelect="true">
            <Expression>NM_000038.6:c.4666dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000029.2" sequenceAccession="NP_000029" sequenceVersion="2" change="p.Thr1556fs">
            <Expression>NP_000029.2:p.Thr1556fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127510.3" sequenceAccession="NM_001127510" sequenceVersion="3" change="c.4666dup">
            <Expression>NM_001127510.3:c.4666dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120982.1" sequenceAccession="NP_001120982" sequenceVersion="1" change="p.Thr1556fs">
            <Expression>NP_001120982.1:p.Thr1556fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127511.3" sequenceAccession="NM_001127511" sequenceVersion="3" change="c.4612dup">
            <Expression>NM_001127511.3:c.4612dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120983.2" sequenceAccession="NP_001120983" sequenceVersion="2" change="p.Thr1538fs">
            <Expression>NP_001120983.2:p.Thr1538fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354895.2" sequenceAccession="NM_001354895" sequenceVersion="2" change="c.4666dup">
            <Expression>NM_001354895.2:c.4666dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341824.1" sequenceAccession="NP_001341824" sequenceVersion="1" change="p.Thr1556fs">
            <Expression>NP_001341824.1:p.Thr1556fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354896.2" sequenceAccession="NM_001354896" sequenceVersion="2" change="c.4720dup">
            <Expression>NM_001354896.2:c.4720dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341825.1" sequenceAccession="NP_001341825" sequenceVersion="1" change="p.Thr1574fs">
            <Expression>NP_001341825.1:p.Thr1574fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354897.2" sequenceAccession="NM_001354897" sequenceVersion="2" change="c.4696dup">
            <Expression>NM_001354897.2:c.4696dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341826.1" sequenceAccession="NP_001341826" sequenceVersion="1" change="p.Thr1566fs">
            <Expression>NP_001341826.1:p.Thr1566fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354898.2" sequenceAccession="NM_001354898" sequenceVersion="2" change="c.4591dup">
            <Expression>NM_001354898.2:c.4591dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341827.1" sequenceAccession="NP_001341827" sequenceVersion="1" change="p.Thr1531fs">
            <Expression>NP_001341827.1:p.Thr1531fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354899.2" sequenceAccession="NM_001354899" sequenceVersion="2" change="c.4582dup">
            <Expression>NM_001354899.2:c.4582dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341828.1" sequenceAccession="NP_001341828" sequenceVersion="1" change="p.Thr1528fs">
            <Expression>NP_001341828.1:p.Thr1528fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354900.2" sequenceAccession="NM_001354900" sequenceVersion="2" change="c.4543dup">
            <Expression>NM_001354900.2:c.4543dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341829.1" sequenceAccession="NP_001341829" sequenceVersion="1" change="p.Thr1515fs">
            <Expression>NP_001341829.1:p.Thr1515fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354901.2" sequenceAccession="NM_001354901" sequenceVersion="2" change="c.4489dup">
            <Expression>NM_001354901.2:c.4489dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341830.1" sequenceAccession="NP_001341830" sequenceVersion="1" change="p.Thr1497fs">
            <Expression>NP_001341830.1:p.Thr1497fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354902.2" sequenceAccession="NM_001354902" sequenceVersion="2" change="c.4393dup">
            <Expression>NM_001354902.2:c.4393dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341831.1" sequenceAccession="NP_001341831" sequenceVersion="1" change="p.Thr1465fs">
            <Expression>NP_001341831.1:p.Thr1465fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354903.2" sequenceAccession="NM_001354903" sequenceVersion="2" change="c.4363dup">
            <Expression>NM_001354903.2:c.4363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341832.1" sequenceAccession="NP_001341832" sequenceVersion="1" change="p.Thr1455fs">
            <Expression>NP_001341832.1:p.Thr1455fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354904.2" sequenceAccession="NM_001354904" sequenceVersion="2" change="c.4288dup">
            <Expression>NM_001354904.2:c.4288dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341833.1" sequenceAccession="NP_001341833" sequenceVersion="1" change="p.Thr1430fs">
            <Expression>NP_001341833.1:p.Thr1430fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354905.2" sequenceAccession="NM_001354905" sequenceVersion="2" change="c.4186dup">
            <Expression>NM_001354905.2:c.4186dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341834.1" sequenceAccession="NP_001341834" sequenceVersion="1" change="p.Thr1396fs">
            <Expression>NP_001341834.1:p.Thr1396fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354906.2" sequenceAccession="NM_001354906" sequenceVersion="2" change="c.3817dup">
            <Expression>NM_001354906.2:c.3817dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341835.1" sequenceAccession="NP_001341835" sequenceVersion="1" change="p.Thr1273fs">
            <Expression>NP_001341835.1:p.Thr1273fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000038.5" sequenceAccession="NM_000038" sequenceVersion="5" change="c.4666dupA">
            <Expression>NM_000038.5:c.4666dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16021317" DB="ClinGen" />
        <XRef Type="rs" ID="587783031" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000038.6(APC):c.4666dup (p.Thr1556fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000491894" Version="5">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4666dup (p.Thr1556fs) AND Carcinoma of colon" Accession="RCV000500725" Version="4">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4666dup (p.Thr1556fs) AND not provided" Accession="RCV000583680" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000038.6(APC):c.4666dup (p.Thr1556fs) AND Familial adenomatous polyposis 1" Accession="RCV000656377" Version="8">
        <ClassifiedConditionList TraitSetID="6265">
          <ClassifiedCondition DB="MedGen" ID="C2713442">Familial adenomatous polyposis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-11" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-11" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2017-06-25" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11852337</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1316610</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14633595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15311282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17293347</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17411426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19029688</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20685668</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20924072</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21110124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22135120</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24750145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26511139</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26819281</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27081525</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30696621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8381579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9101302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9824584</ID>
        </Citation>
        <DescriptionHistory Dated="2021-04-08">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-02-16">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6265" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, ADENOMATOUS INTESTINAL</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APC-Associated Polyposis Conditions</ElementValue>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 1</ElementValue>
                <XRef ID="MONDO:0021056" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED</ElementValue>
                <XRef Type="Allelic variant" ID="611731.0028" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0049" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0035" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0042" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0043" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611731.0021" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FAP1</ElementValue>
                <XRef Type="MIM" ID="175100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.</Attribute>
                <XRef ID="NBK1345" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552303" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000321103" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520047" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000172265" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520077" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501393" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512300" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515899" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501794" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593435" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330056" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558907" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301519</ID>
                <ID Source="BookShelf">NBK1345</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368914</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <XRef ID="C2713442" DB="MedGen" />
              <XRef ID="MONDO:0021056" DB="MONDO" />
              <XRef Type="MIM" ID="175100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1349047" SubmissionDate="2017-10-31" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_000038.5:c.4666dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000691753" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Thr1556Asnfs*3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4666dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3178674</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1517825" SubmissionDate="2018-06-05" DateLastUpdated="2018-06-08" DateCreated="2018-06-08">
        <ClinVarSubmissionID localKey="SUB4109361" submittedAssembly="GRCh38" title="SUB4109361" />
        <ClinVarAccession Accession="SCV000778309" DateUpdated="2018-06-08" DateCreated="2018-06-08" Type="SCV" Version="1" SubmitterName="National Molecular Genetics Centre of Cancer Research, N.N. Alexandrov National Cancer Centre of Belarus" OrgID="506329" OrganizationCategory="laboratory" OrgAbbreviation="NMGCCR" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Detected in patient with clinical features of Gardner syndrome. Emory Genetics Laboratory Classification Definitions Pathogenic: a. Variants predicted to result in the loss of protein function in a gene for which this is a known mechanism of disease (may or may not have been previously reported in patients with disease) 1. frameshift (an insertion or deletion that is not a multiple of 3 nucleotides).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>caucasian</Ethnicity>
              <GeographicOrigin>Republic of Belarus</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Clinical features observed in this individual</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>ABI 3500</NamePlatform>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Description>bi-direction sequence of the entire coding region APC gene</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0005227" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001067" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0006771" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004394" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC">
              <Name>APC, WNT signaling pathway regulator</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000038.5:exon 16</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs1114167560" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4666dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4109361</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1147621" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="chr5:112175950-112175951:408fcbd1f57d3155ad7c35d1c97106fe-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000591177" DateUpdated="2021-04-13" DateCreated="2017-08-28" Type="SCV" Version="3" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The APC p.Thr1556AsnfsX3 variant was identified in 18 of 4600 proband chromosomes (frequency: 0.004) from individuals or families with colorectal cancer, and was not identified in 150 control chromosomes from healthy individuals (Aceto 2005, Friedl 2005, Han 2011, Kanter-Smoler 2008, Kohoutova 2002, Liu 2007, Out 2015, Palacio_Rua 2014, Plawski 2008, Rivera 2011, Schwarzova 2013, Stekrova 2007, Vandrovcova 2004), however, an insufficient number of controls were included in these studies to determine the frequency of this variant in the general population. The variant was also identified in HGMD, InSiGHT Colon Cancer Gene Variant Database, â€šÃ„ÃºZhejiang Colon Cancer Databaseâ€šÃ„Ã¹ and UMD (7X as a un validated variant). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The p.Thr1556AsnfsX3 duplication variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1556 and leads to a premature stop codon 3 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the APC gene are an established mechanism of disease in familial adenomatous polyposis and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="GA" referenceAllele="G" start="112175951" stop="112175951" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4023492" SubmissionDate="2022-01-07" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkbkW51NDN4cK_yDJD6rtm3k|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002053563" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant inserts 1 nucleotide in exon 16 of the APC gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with more than 10 patients with familial adenomatous polyposis (PMID: 15024739, 17411426, 22987206, 16134147, 11852337, 18433509, 20223039, 20685668, 24750145, 30696621). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4666dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10906337</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5396944" SubmissionDate="2022-11-15" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="NM_000038.6:c.4666dup|OMIM:175100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002758617" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Human Genetics Bochum, Ruhr University Bochum" OrgID="508444" OrganizationCategory="laboratory" OrgAbbreviation="HGRUB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG criteria used to clasify this variant: PVS1, PM2, PS4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.6:c.4666dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12286006</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7568102" SubmissionDate="2023-10-23" DateLastUpdated="2023-10-28" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="4599|OMIM:175100" />
        <ClinVarAccession Accession="SCV004044724" DateUpdated="2023-10-28" DateCreated="2023-10-21" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="5" alternateAllele="AA" referenceAllele="A" start="112175957" stop="112175957" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">4599</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13911051</SubmissionName>
          <SubmissionName>SUB13922314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1835307" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4179918|MedGen:C2713442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000941363" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9824584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1316610</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27081525</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8381579</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22135120</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15311282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17293347</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14633595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9101302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11852337</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17411426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19029688</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20685668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20924072</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21110124</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26511139</ID>
          </Citation>
          <Comment>A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, Invitae). This suggests that deletion of this region of the APC protein is causative of disease. For these reasons, this variant has been classified as Pathogenic. This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. Experimental studies have shown that this premature translational stop signal affects APC function (PMID: 14633595). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 428112). This variant is also known as 4663insA. This premature translational stop signal has been observed in individuals with familial adenomatous polyposis (PMID: 9101302, 11852337, 17411426, 19029688, 20685668, 20924072, 21110124, 26511139). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr1556Asnfs*3) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1288 amino acid(s) of the APC protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.112175951_112175952insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2713442" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1129581" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2017-06-25">
        <ClinVarSubmissionID localKey="a02981|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000579826" DateUpdated="2024-05-01" DateCreated="2017-06-25" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14633595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24750145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26819281</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30696621</ID>
          </Citation>
          <Comment>The c.4666dupA pathogenic mutation, located in coding exon 15 of the APC gene, results from a duplication of A at nucleotide position 4666, causing a translational frameshift with a predicted alternate stop codon (p.T1556Nfs*3). This mutation has been reported in two unrelated Italian polyposis patients (Gismondi V et al. Hum. Mutat. 1997;9(4):370-3), and a Spanish patient diagnosed with osteoma who had no family history of cancer (Rivera B et al. Ann Oncol. 2011 Apr;22(4):903-9). It was also observed in a two-year-old boy with a Gardner-associated fibroma, lumbar paraspinal desmoid and multiple other lesions; both parents tested negative for the mutation (Kiessling P et al. Cold Spring Harb. Mol. Case Stud. 2019 Apr;5(2)). Of note, this alteration is also designated as 4663insA in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000038.5:c.4666dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1129581" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5396944" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1517825" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005227" MappingRef="HP">
        <MedGen CUI="C1868071" Name="Adenomatous colonic polyposis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7568102" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1517825" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001067" MappingRef="HP">
        <MedGen CUI="C0027830" Name="Neurofibroma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1517825" TraitType="Disease" MappingType="XRef" MappingValue="175100" MappingRef="OMIM">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1835307" TraitType="Disease" MappingType="XRef" MappingValue="C2713442" MappingRef="MedGen">
        <MedGen CUI="C2713442" Name="Familial adenomatous polyposis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1517825" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006771" MappingRef="HP">
        <MedGen CUI="C0278804" Name="Duodenal adenocarcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1147621" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4023492" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1517825" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004394" MappingRef="HP">
        <MedGen CUI="C0236048" Name="Gastric polyposis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1349047" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

